Company Overview and News

14
Are Institutions Abandoning Tesla?

53m seekingalpha
Tesla’s institutional ownership has been very high in recent years; large-scale institutional ownership has helped to keep a floor under the share price.
GM.WS.A GM.WS.B GM.WS.C GM GM.WSB

14
Allison Transmission Is A Buy

7h seekingalpha
Shares of Allison Transmission have been this inexpensive only twice since 2012. The shares rallied nicely from those valuations and I think history is about to repeat itself.
GM.WS.A GM.WS.B GM.WS.C GM ALSN GM.WSB

14
Elon Musk's Twitter outburst rattles investors

8h nzherald.co.nz
Four days after Tesla's fourth-largest shareholder urged "a time of quiet and peace," chief executive Elon Musk lobbed one of his nastiest stink bombs yet: an accusation about an organizer of the Thailand cave rescue that investors say is a major distraction from his mission running the embattled automaker.
GM.WS.A GM.WS.B GM.WS.C GM GM.WSB

62
4 GARP Stocks to Buy Now

10h investorplace
Investors don’t need to pick between growth and value — at least not entirely. Growth at a reasonable price stocks — or GARP stocks — are a good fit for investors who are looking for equities that can rise significantly over the longer time, but are wary about owning expensive shares. These investors are looking for companies with relatively cheap stocks, growing businesses, and good long-term growth prospects.
AMZN SODA TM GM.WS.A GM.WS.B GM.WS.C SBUX BBY GM GM.WSB

14
Ford to Pay $299.1 Million to Settle Takata Consumer Lawsuit - Bloomberg

12h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
7261 MZDAY TM TYT TOYOF DDAIF VLKAF GM.WS.A GM.WS.B MZDAF GM.WS.C 7203 GM GM.WSB

21
What Should Investors Do With Tesla (TSLA) Stock?

12h zacks
Shares of Tesla (TSLA - Free Report) plummeted Monday after chief executive Elon Musk once again found himself in hot water after he posted a rude comment about a British cave explorer regarding the Thailand cave rescue mission. Although the CEO’s statements were crass, they don’t really impact Tesla’s core business. So let’s assess TSLA stock at what could be a buying point.
GM.WS.A TWTR GM.WS.B GM.WS.C GM GM.WSB VLKAY

14
Flash - Tesla shares tumble after Musk tweet controversy - France 24

14h france24
Tesla shares stumbled Monday as chief executive Elon Musk faced criticism over a public spat with a British diver who worked on the Thai soccer team rescue.
GM.WS.A GM.WS.B GM.WS.C GM GM.WSB

14
Q&A: World Trade Organization's role in US-China dispute

17h nzherald.co.nz
FRANKFURT, Germany (AP) — China is using the World Trade Organization as one of its weapons to fight back against the latest tariffs proposed by U.S. President Donald Trump.
GM.WS.A GM.WS.B GM.WS.C GM GM.WSB

14
Why The Stock Market Hasn't Buckled Under The Trade Tensions

17h seekingalpha
After some wobbles when trade tensions hit the headlines, the markets seem to have regained their footing.
MS.PRI GM.WS.A MS.PRK GM.WS.B GM.WS.C MS.PRE MS.PRF MS.PRG MS GM MS.PRA GM.WSB

18
Should Value Investors Pick General Motors (GM) Stock?

19h zacks
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process.
NTRS GTT GM.WS.A NTRSP GM.WS.B GM.WS.C GM GM.WSB

17
RPT-Rebates protect Canada's auto industry from retaliatory tariffs

22h reuters
TORONTO, July 16 (Reuters) - Canadian government customs provisions are expected to soften the blow on the country’s powerful automotive industry from retaliatory tariffs on U.S. steel, according to trade lawyers and industry leaders bracing for higher costs.
MGA GM.WS.A TM GM.WS.B MG LIMAF GM.WS.C 7203 TYT GM GM.WSB TOYOF

19
Why STAG Is A Best-In-Class Sleep Well At Night REIT

23h seekingalpha
Some of you have asked me last week why STAG Industrial (STAG) was not listed in my top 10 “sleep well at night” list. As you may recall, I penned an article titled, 10 Great REITs To Own For The Next 10 Years,” which included the following best-in-class picks:
KIM.PRI TM STAG.PRB STAG.PRC HTA O.PRF LTC OPRF KIM.PRM KIM.PRL KIM.PRK KIM.PRJ GM.WS.A GM.WS.B GM.WS.C GM STAG KIM STAG.PRA F O TYT TOYOF PLD SPG.PRJ 7203 STAG.PRBCL SPG FCAU GM.WSB

14
Payton Planar - A Hidden Gem Under The Electric Vehicle Hood

2018-07-16 seekingalpha
Electric Vehicles (EVs) are expected to hit the road en masse over the next several years. Instead of guessing who will win the car manufacturers' race, it’s wise to look under the hood for niche suppliers.
SXI ABB LEA PAY GM.WS.A GM.WS.B GM.WS.C VSH GM GM.WSB POWI

17
Rebates protect Canada's auto industry from retaliatory tariffs - Channel NewsAsia

2018-07-16 channelnewsasia
Canadian government customs provisions are expected to soften the blow on the country's powerful automotive industry from retaliatory tariffs on U.S. steel, according to trade lawyers and industry leaders bracing for higher costs.
MGA GM.WS.A TM GM.WS.B MG LIMAF GM.WS.C 7203 TYT GM GM.WSB TOYOF

18
Rebates protect Canada's auto industry from retaliatory tariffs

2018-07-16 reuters
TORONTO (Reuters) - Canadian government customs provisions are expected to soften the blow on the country’s powerful automotive industry from retaliatory tariffs on U.S. steel, according to trade lawyers and industry leaders bracing for higher costs.
MGA GM.WS.A TM GM.WS.B MG LIMAF GM.WS.C 7203 TYT GM GM.WSB TOYOF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

4h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

6h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 37045V126